KING OF PRUSSIA, Pa., June 13, 2018 /PRNewswire/ -- Greenphire, the global leader in financial software for clinical trials, today announced enhancements to its eClinicalGPS site payment solution, expanding configuration and administration options, providing CROs and sponsors unmatched capability, flexibility, and control. With these enhancements, Greenphire is positioned to take an even more collaborative and strategic role with CRO and sponsor partners in identifying the delivery model, whether self-service, full service, or somewhere in between, to maximize the ROI in site payment automation.
Increasing trial complexity and expanding industry emphasis on site centricity are contributing to the rapid evolution of grant payment management. The latest enhancements to Greenphire's SaaS-based eClinicalGPS make it possible for more sponsors and CROs to automate their investigator payment processes globally.
"A one-size-fits-all approach to site payments is not scalable or sustainable in today's clinical research landscape," said Jim Murphy, CEO of Greenphire. "Sponsors and CROs focused on optimizing payment processes need advanced financial features which can be configured to support their unique workflows, as well as those of their investigative sites around the world."
Among the new features and functionality supporting greater sponsor and CRO payment flexibility are:
eClinicalGPS is the site payment software of choice for global sponsors and CROs looking to automate investigator grant payments enterprise-wide. Backed by a team of experts in global financial software development for clinical research that delivers measurable ROI, the SaaS-based solution leads the industry in technology sophistication and adoption around the world.
For more information, or to schedule a demo, contact sales@greenphire.com.
About Greenphire
Greenphire is the global leader in clinical trial payment automation. Greenphire is exclusively focused on optimizing clinical trial performance by streamlining payment processes from sponsors and CROs to sites and patients. The choice of industry leaders worldwide, Greenphire supports site centricity and sustainability, increases patient engagement and retention, and provides more comprehensive financial data, resulting in better trials. Learn more at www.greenphire.com.
Media Contact:
Kathleen Fusco
(267) 828-4862
Kathleen.Fusco@greenphire.com
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
FDA Grants Priority Review to Merck’s sBLA for Winrevair After Early Success in ZENITH PAH Trial
July 2nd 2025Merck’s bid to update Winrevair’s label advances with FDA priority review, backed by Phase III ZENITH data showing a 76% reduction in major morbidity and mortality events in patients with pulmonary arterial hypertension.